Invenra Inc.

Welcome

BiotechProfiles™ is the premier resource for jobs, company information, professional networking and productivity tools in the Madison, Wisconsin biotechnology and medical device industry. Recognized as one of the premier emerging biotechnology clusters in the U.S., this robust industry sector comprises nearly 10,000 employees in approximately 150 companies. BiotechProfiles also maintains a unique directory of the largest 250 pharmaceutical companies worldwide, including business development contacts whenever available. This tool is indispensable for executives pursuing strategic alliances and technology licenses.
Designed as a suite of easy to use, searchable databases that are continually updated, BiotechProfiles serves the needs of biotech business development and operational executives in early stage companies, as well as the general public. With these tools you can quickly bypass the data collection and screening stage and immediately focus on solving your strategic partnering or operational needs. We've assembled your background data for you!
  Next »

BiotechProfiles is also the premier site for data on Biotechnology Companies in Madison Wisconsin, Biotechnology Jobs in Madison Wisconsin

Biotechnology Companies in Madison Wisconsin; Biotechnology Jobs in Madison Wisconsin
  « Previous | Next »

Biotechnology Business Development, Partnering and Strategic Alliances

Biotechnology Business Development, Partnering and Strategic Alliances
  « Previous | Next »

Madison Biotechnology Companies; Madison Biotechnology Jobs

Madison Biotechnology Companies; Madison Biotechnology Jobs
  « Previous | Next »

List or rank of Largest Pharmaceutical Companies Worldwide

List of rank of Largest Pharmaceutical Companies Worldwide
  « Previous

Advertisement

Company Profile

Invenra, Inc., is a biotechnology company focused on the discovery and development of multispecific antibodies for immuno-oncology. Invenra’s proprietary B-Body™ and SNIPER™ technologies are used to develop novel antibodies that can bind to two or more specific therapeutic targets and mimic the natural IgG antibodies made by the human body. The B-Body™ platform enables the rapid identification of an optimal combination of epitope, affinity and geometry [of an antibody] using high throughput in-format screening for function in cell-based assays, while maintaining the biophysical characteristics needed for lead development. Importantly, the B-Body™ platform is designed to create advantages for candidate discovery with novel mechanisms of action and ease of manufacturing. Thousands of B-Body™ multispecifics can be assessed weekly with high-throughput in-format screening in functional assays. Invenra has developed its own pipeline of bispecifics and has partnered with several biotechnology and pharmaceutical companies who leverage Invenra’s technologies to identify molecules with biological relevance for drug development.
Business Sectors
Pharmaceuticals Human Diagnostics  
Med or Lab Devices   Lab Reagents or Services  
Drug Manufacturing   Food & Agribusiness  
CRO   Bioinformatics or Software  
    Other  
Company History
Invenra Inc.
Address 505 South Rosa Road, Suite 235
[Map] Madison
WI
53719
Phone 608-441-8319
Fax
Website Link
Head Roland Green, PhD
Company Statistics
Global Headcount 20
Local Headcount 20
Year Founded 2011
Ownership Private
Stock Exchange

Parent Company
Divisional Level
Senior Level
Global Headcount
Website
Stock Exchange
Reference Documents
News/Profiles
2018 - Invenra Signs Deal Worth over $325 Million [View]
2017 - Invenra Teams Up With Merck [View]
2017 - Invenra Lands $3 million to Fight Cancer [View]
2016 - Invenra Raises $3 million [View]
2015 - Invenra Raises Another $2 Million [View]
2015 - Invenra Raises $2 Million [View]
2015 - Invenra to Collaborate with Oxford BioTherapeutics [View]
2015 - Faster, Smaller, Cheaper [View]